Miscellaneous erythropoiesis agents

Reblozyl 25 mg lyophilized powder for injection Images

Generic Name: luspatercept

This medication has been identified as Reblozyl 25 mg lyophilized powder for injection. It is supplied by Celgene Corporation.

Reblozyl is used in the treatment of Myelodysplastic Syndrome; Beta Thalassemia; Anemia and belongs to the drug class miscellaneous erythropoiesis agents. Reblozyl 25 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).

Images

Reblozyl (Luspatercept [ lus-pat-er-sept ])-medicine-25 mg lyophilized powder for injection

Reblozyl
Generic Name: luspatercept [ lus-pat-er-sept ]
Imprint: medicine
Strength: 25 mg lyophilized powder for injection
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Miscellaneous erythropoiesis agents
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 59572-0711
Inactive Ingredients:
Latest News
Related Drugs